Drugs / Minprostin
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT01255839 Comparator | Dec 2002 → Sep 2005 | — | Glostrup University Hospital, Copenhagen | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Minprostin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01255839 ↗ |
| Modality | Other / unclassified | “The prostaglandin 2 minprostin (3mg) was applied vaginally” NCT01255839 ↗ |
| Route | Other | “The prostaglandin 2 minprostin (3mg) was applied vaginally” NCT01255839 ↗ |